Pharmacokinetics of terbutaline during pregnancy
Tóm tắt
Terbutaline in plasma was determined in three groups of women by gas chromatography-mass spectrometry. Eight women received a single i.v. dose of 0.25 mg terbutaline sulphate during pregnancy and 3–6 months after delivery. Mean plasma clearance was 29% higher during pregnancy than after delivery. There was a subsequent decrease in mean terminal half-life from 5.3 to 3.7 h and in mean residence time from 5.3 to 3.4 h. There was no change in volume of distribution. A second group of pregnant women in premature labour (n=8) received oral terbutaline 5 mg t.d.s. The dosing was repeated after delivery. The mean steady state plasma concentration of terbutaline was about 30% lower during pregnancy than after delivery. A third group of women in preterm labour (n=8) was treated with an i.v. infusion of terbutaline. The concentrations of terbutaline found on cessation of uterine contractions ranged between 12.8 and 31.5 ng/ml. At present there is no basis for formulation of a “therapeutic plasma level” of terbutaline for the treatment of preterm labour.
Tài liệu tham khảo
Hemminki E, Starfield B (1978) Prevention and treatment of premature labour by drugs: Review of controlled clinical trials. Br J Obstet Gynaecol 85: 411–417
Gomeni C, Gomeni R (1978) Interactive package for pharmacokinetic analysis. Comp Biomed Res 11: 345–361
Parker WA (1984) Effects of pregnancy on pharmacokinetics. In: Benet LZ, et al. (eds) Pharmacokinetic basis of drug treatment. Raven Press, New York, pp 249–268